Research and influencing blog
Welcome to our research and influencing blog. This is where we share our latest research and campaigns updates, summaries of recent findings and explore key issues affecting people with bowel cancer. We also share information from medical experts and links to further information and resources.
Party political conferences 2023 and bowel cancer - what you need to know
We work hard to make sure that all politicians take the needs of bowel cancer patients seriously. Last month that work took us to the Labour, Conservative, SNP and DUP party conferences.
Changes to cancer waiting times in England should lead to improvements in diagnosis
Today, NHS England announced proposed changes to cancer waiting times with the aim to streamline the existing nine performance standards into three key targets.
Lack of political leadership in Northern Ireland sees bowel cancer services put at risk
Latest cancer waiting times show the downward spiral of the healthcare system in Northern Ireland. Bowel cancer waiting times must be given the priority patients and their families deserve.
Our campaigning has put an end to the ban on ‘treatment breaks’ for advanced bowel cancer patients
NHS England have removed a rule that prevented advanced bowel cancer patients from taking a break longer than six weeks from treatment if they were receiving the drugs cetuximab and panitumumab.
A round up of exciting new bowel cancer research announced at ASCO
Read our round up of the news and research that emerged from the world’s largest cancer conference, the annual meeting of the American Society of Clinical Oncology (ASCO).
Ben Lake MP, tells us why launching the All-Party Parliamentary Group on Bowel Cancer is so important
Read our blog by Ben Lake MP about how the newly formed All-Party Parliamentary Group on Bowel Cancer will help put bowel cancer on the political agenda.
We won't let the Government forget its 'war on cancer'
Join us today by signing our petition calling for an ambitious, fully funded long term strategy for cancer.